arrow_back Trending Legislation
Share share

New Sickle Cell Treatment Centers: Coordinated Lifelong Care and Support

This act establishes a national network of specialized Sickle Cell Disease Treatment Centers using a "hub-and-spoke" model to ensure coordinated, lifelong care for patients. The program aims to improve health outcomes, facilitate the transition from pediatric to adult care, and provide crucial support, including assistance with health insurance access and transportation costs for treatment. It also mandates increased public awareness and data collection regarding the disease.
Key points
Creation of specialized treatment networks (hubs and spokes) offering comprehensive care, including advanced treatments like gene therapy and stem cell transplants.
Financial assistance available to patients for securing health insurance (premiums/cost-sharing) and reimbursement for travel to treatment centers.
Integration of community organizations to address social barriers to health, such as food insecurity, housing issues, and lack of transportation.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Sickle Cell Disease Treatment Centers Act of 2024
Print number: HR 9872
Sponsor: Rep. Lee, Barbara [D-CA-12]
Process start date: 2024-09-27
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about New Sickle Cell Treatment Centers: Coordinated Lifelong Care and Support

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 9872.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-09-27.

What are the main provisions?

Key points include:

  • Creation of specialized treatment networks (hubs and spokes) offering comprehensive care, including advanced treatments like gene therapy and stem cell transplants.
  • Financial assistance available to patients for securing health insurance (premiums/cost-sharing) and reimbursement for travel to treatment centers.
  • Integration of community organizations to address social barriers to health, such as food insecurity, housing issues, and lack of transportation.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Lee, Barbara [D-CA-12].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

Analysis and Potential Impact of HR 9872

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health